65,437 trials
Dengue
Primary: Percentage of Participants Who Are YF and Dengue Virus (DENV)-Naive at Baseline and Are Seroprotected Against YF on Day 30 as Measured by Plaque Reduction Neutralization…
Systemic Sclerosis
Primary: Raynaud's Condition Scale — 5; 5; 6.5; 3 score on a scale — p=0.256
Crohn's Disease
Primary: Change in Simple Endoscopic Score for Crohn's Disease (SES-CD) (Paired Segments) From Baseline at Week 12 as Determined by a Blinded Central Reader. — -2.3 Units on a…
Hemophilia A
Primary: Hemophilia Joint Health Score (HJHS) 2.0 — 3.77 score on a scale
Diabetes
Primary: Diagnosis-Treatment — 31.7; 35.0; 29.1; 31.9 CPV diagnosis-treatment percentage score
Edematous Fibrosclerotic Panniculopathy (Cellulite)
Primary: 2-level Composite Responders for the Target Buttock — 16; 4; 194; 209 Participants — p=0.006
Metabolic Syndrome X
Primary: Waist Circumference at Week 12. — 97.6; 97.2 centimeters — p=<0.001
Pain
Primary: Correlation Between Change in Pain Intensity and TBW at 30 Minutes Post-treatment — -0.03 correlation coefficient
Schizophrenia
Primary: Mismatch Negativity (MMN) — .086; 0.31 micro volts
Hepatitis B
Primary: Change of the Rates of Participants Who Adherent to Recommended Clinical Care for the Monitoring of Chronic HBV Infection — 200; 113; 225; 140 Participants
Sinusitis
Primary: Safety Assessments — 2 Participants
Nocturia
Primary: Change in # of Mean Nocturic Episodes Per Night — -1.4; -1.4; -1.6; -1.2 nocturic episodes per night
Astigmatism Bilateral
Primary: Lens Fit - Horizontal Centration — 0; 0; 6; 4 percentage of lenses
Venous Leg Ulcer
Primary: Relative Reduction of Reference Ulcer Area After 4 Weeks of Treatment on Top of Standard of Care Compared With Baseline Reference Ulcer Area (W000) Assessed During Study…
Depression · Anxiety
Primary: Patient Health Questionnaire - 8 (PHQ-8) - Depression Severity Module — 2.43; 9.28 score on a scale